Several real-world instances demonstrate how ML is already enhancing diabetes CDSS, from predicting diabetes risk with remarkable accuracy to optimizing insulin dosing and offering personalized guidance to patients based on their real-time blood sugar data. This evidence concerns the gene INS and diabetes mellitus.